Researcher.Life Logo

Current Vascular Pharmacology : Impact Factor & More

eISSN: 1875-6212pISSN: 1570-1611

Key Metrics

CiteScore
6.3
H-Index
67
Impact Factor
< 5
SJR
Q1Pharmacology
SNIP
0.8
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Current Vascular Pharmacology

Current Vascular Pharmacology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher BENTHAM SCIENCE PUBL LTD
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2003
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Current Vascular Pharmacology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Current Vascular Pharmacology

Metalloproteinases 2 and 9 as Biomarkers in Acute Elevation of Blood Pressure.
  • 9 May 2026
  • Current vascular pharmacology
The Use of Colchicine in Cardiovascular Disease: Anti-Inflammatory Mechanisms and Clinical Utility.
  • 8 May 2026
  • Current vascular pharmacology
Is the Cardiovascular Risk Increased in Patients with Isolated Systolic Hypertension and Anemia?
  • 8 May 2026
  • Current vascular pharmacology
Periodontal Disease and Cardiovascular Risk Factors.
  • 7 May 2026
  • Current vascular pharmacology
Chitosan-Saponin-Bentonite Nanocomposites Prevent Doxorubicin-Induced Cardiovascular Toxicity by Inhibiting Oxidative Stress and Apoptosis.
  • 4 May 2026
  • Current vascular pharmacology
Peripheral Arterial Disease Outcome in Patients with ESRD on Hemodialysis: A Study from a Developing Country.
  • 30 Apr 2026
  • Current vascular pharmacology
Metalloproteinases 2 and 9 as Biomarkers in Acute Elevation of Blood Pressure.
  • 9 May 2026
  • Current vascular pharmacology
The Use of Colchicine in Cardiovascular Disease: Anti-Inflammatory Mechanisms and Clinical Utility.
  • 8 May 2026
  • Current vascular pharmacology
Is the Cardiovascular Risk Increased in Patients with Isolated Systolic Hypertension and Anemia?
  • 8 May 2026
  • Current vascular pharmacology
Periodontal Disease and Cardiovascular Risk Factors.
  • 7 May 2026
  • Current vascular pharmacology
Chitosan-Saponin-Bentonite Nanocomposites Prevent Doxorubicin-Induced Cardiovascular Toxicity by Inhibiting Oxidative Stress and Apoptosis.
  • 4 May 2026
  • Current vascular pharmacology
Peripheral Arterial Disease Outcome in Patients with ESRD on Hemodialysis: A Study from a Developing Country.
  • 30 Apr 2026
  • Current vascular pharmacology

FAQs on Current Vascular Pharmacology